Susanne Klint, Joachim Feldwisch, Lindvi Gudmundsdotter, Karin Dillner Bergstedt, Elin Gunneriusson, Ingmarie Höidén Guthenberg, . . . Fredrik Y. Frejd. (2023). Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis. Taylor & Francis Group.
Chicago Style (17th ed.) CitationSusanne Klint, et al. Izokibep: Preclinical Development and First-in-human Study of a Novel IL-17A Neutralizing Affibody Molecule in Patients with Plaque Psoriasis. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationSusanne Klint, et al. Izokibep: Preclinical Development and First-in-human Study of a Novel IL-17A Neutralizing Affibody Molecule in Patients with Plaque Psoriasis. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.